Bolt Biotherapeutics, Inc. (BOLT) Financials
BOLT Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2023-09-30 | 175.4 million | 47.1 million |
2023-06-30 | 190.7 million | 48.6 million |
2023-03-31 | 206.2 million | 48.5 million |
2022-12-31 | 227.8 million | 56.3 million |
BOLT Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2023-09-30 | -16.9 million | 2.3 million |
2023-06-30 | -15.1 million | 2.4 million |
2023-03-31 | -23.4 million | 2.5 million |
2022-12-31 | -18.1 million | 2.1 million |
BOLT Net Income
No data available :(
BOLT Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2023-09-30 | 119.7 million | - | 20.9 million |
2023-06-30 | 125.9 million | - | 21.5 million |
2023-03-31 | 126.4 million | - | 22.1 million |
2022-12-31 | 168.9 million | - | 22.6 million |
BOLT Shares Outstanding
BOLT Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2023-09-30 | 165000 | 15.0 million | 5.8 million | - |
2023-06-30 | 32000 | 15.6 million | 5.6 million | - |
2023-03-31 | 3000 | 14.6 million | 5.6 million | - |
2022-12-31 | 184000 | 16.8 million | 5.6 million | - |
BOLT Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2023-09-30 | 2.5 million | 462000 |
2023-06-30 | 1.4 million | 1.2 million |
2023-03-31 | 1.8 million | 1.2 million |
2022-12-31 | 1.4 million | 1.2 million |
BOLT
Price: $1.10
52 week price:
Payout Ratio Range:
Earnings Per Share: -1.83 USD
P/E Ratio: -0.58
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Volume: 121100
Market Capitalization: 50.3 million
Average Dividend Frequency: 4